About this trial
The overall objective of this study is to assess whether robot-assisted upper-limb group rehabilitation can be effectively delivered by using a camera-based system equipped with machine learning algorithms to track the quality of the exercise performance and provide feedback accordingly. To address this question, we plan to carry out a randomized clinical trial to compare outcomes in subjects receiving robot-assisted upper-limb rehabilitation during individual (i.e., one-on-one) sessions and in subjects receiving robot-assisted upper-limb rehabilitation during group (i.e., up to three subjects) sessions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Have had a history of ischemic cerebrovascular accident (CVA) within middle cerebral artery (MCA) or anterior cerebral artery (ACA) territory
CVA occurred between six months and six years ago
Moderate to severe UE impairment, FMA-UE score between 15 and 45
Mini-Mental State Examination (MMSE) score >23 and being able to safely follow three-step commands
Disqualifiers
Advanced musculoskeletal pathology or recent fractures in the impaired UE
Previous diagnosis of neurological diseases other than stroke
Severe limitation of passive range of motion or spasticity (Modified Ashworth Scale for spasticity at <3 for UE muscles)
Hemorrhagic CVA or involvement of the posterior cerebral artery
Trial design
Parallel
Treatments tested in this trial
BURT
DeviceRobot-assisted upper-limb individual (i.e. one-on-one) rehabilitation will be delivered using the BURT system by Barrett Technology
BURT + PostureCheck
DeviceRobot-assisted upper-limb group (i.e. up to three subjects) rehabilitation will be delivered using the BURT system by Barrett Technology + PostureChek (a camera-based system to track the quality of the exercises)
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE) at 7-8 weeks
Standard assessment of the severity of upper-limb motor impairments
Secondary outcomes
Change from baseline Wolf Motor Function Test (WMFT) at 7-8 weeks
Standard assessment of functional limitations
Change from baseline Motor Activity Log (MAL) at 7-8 weeks
Self-report of amount and quality of use of the stroke-affected upper limb
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Spaulding Rehabilitation Hospital
Lead sponsor
Barrett Technology
Collaborator